default author photo

Eleanor FG Neal

University of Melbourne - Infection and Immunity

SCHOLARLY PAPERS

4

DOWNLOADS

329

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

The Immunogenicity, Reactogenicity, and Safety of a Bivalent mRNA or Protein-Based COVID-19 Vaccine Given as a Fourth Dose in Healthy Adults in Australia: a Randomised Controlled Trial

Number of pages: 29 Posted: 02 Oct 2024
University of Melbourne - Murdoch Children's Research Institute, University of Melbourne - Murdoch Children's Research Institute, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, Murdoch Children's Research Institute, Murdoch Children's Research Institute, Murdoch Children's Research Institute, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, Murdoch Children's Research Institute, Murdoch Children's Research Institute, University of Melbourne - Infection and Immunity, University of Melbourne - Murdoch Children's Research Institute, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Murdoch Children's Research Institute, University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity and University of Melbourne - Murdoch Children's Research Institute
Downloads 129 (561,789)
Citation 1

Abstract:

Loading...

COVID-19, SARS-CoV-2, vaccination, booster, antibody, immunity

2.

Immunogenicity, Safety, and Reactogenicity of a Half- Versus Full-Dose BNT162b2 (Pfizer-Biontech) Booster Following a Two-Dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac Priming Schedule in Mongolia: A Randomised, Controlled, Non-Inferiority Trial

Number of pages: 25 Posted: 03 Apr 2023
National Center for Communicable Diseases, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, Onoshmed Laboratory, National Center for Communicable Diseases, Onoshmed Laboratory, Sukhbaatar District Health Centre, First Central Hospital of Mongolia - General Laboratory of Clinical Pathology, University of Melbourne - Infection and Immunity, First Central Hospital of Mongolia - General Laboratory of Clinical Pathology, University of Melbourne - Infection and Immunity, Mongolian National University of Medical Sciences, University of Melbourne - Infection and Immunity, Bayangol District Health Centre, First Central Hospital of Mongolia - General Laboratory of Clinical Pathology, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Murdoch Children's Research Institute, National Center for Communicable Diseases, University of Melbourne - Murdoch Children's Research Institute, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, Ministry of Health, Mongolia, National Center for Communicable Diseases, Onoshmed Laboratory, National Centre for Public Health (Mongolia), University of Melbourne - Infection and Immunity and University of Melbourne - Infection and Immunity
Downloads 123 (584,619)

Abstract:

Loading...

COVID-19, SARS-CoV-2, vaccination, fractional dose, half-dose, booster, BNT162b2

3.

Association Between Village Coverage of 13-Valent Pneumococcal Conjugate Vaccine and Vaccine-Type Pneumococcal Carriage Among Children Aged 0 – 59 Months With Pneumonia in Papua New Guinea: An Observational Study

Number of pages: 24 Posted: 19 Nov 2025
Papua New Guinea Institute of Medical Research, University of Melbourne - Infection and Immunity, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, University of Melbourne - Murdoch Children's Research Institute, St George’s University London - Institute for Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Murdoch Children's Research Institute, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, Papua New Guinea Institute of Medical Research - Population Health and Demography Unit, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases and University of Melbourne - Murdoch Children's Research Institute
Downloads 42 (1,157,785)

Abstract:

Loading...

pneumococcal conjugate vaccine, PCV13, vaccine-type carriage, indirect effects, Coverage, Papua New Guinea

4.

Association between Village Coverage of 13-Valent Pneumococcal Conjugate Vaccine and Vaccine-Type Pneumococcal Carriage among Children Aged 0 – 59 Months with Pneumonia in Papua New Guinea: An Observational Study

Number of pages: 20 Posted: 30 Sep 2025
Papua New Guinea Institute of Medical Research, University of Melbourne - Infection and Immunity, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, University of Melbourne - Murdoch Children's Research Institute, St George’s University London - Institute for Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Murdoch Children's Research Institute, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, Papua New Guinea Institute of Medical Research - Population Health and Demography Unit, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, University of Melbourne - Murdoch Children's Research Institute and Independent
Downloads 35 (1,249,711)

Abstract:

Loading...

Pneumococcal conjugate vaccine (PCV13), Pneumococcal carriage, Vaccine effectiveness, Indirect effects, Papua New Guinea